UNC School of Medicine researchers used MRI to document crucial differences in the visual processing system in the brains of infants who went on to be diagnosed with autism. CHAPEL HILL, N.C.–(BUSINESS WIRE)–For the first time, scientists have found that brain differences in the visual brain systems of infants who later are diagnosed with autism … [Read more…]

WILMINGTON, Del.–(BUSINESS WIRE)–$INCY #EHA2022–Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from its oncology portfolio will be presented at the upcoming European Hematology Association 2022 (EHA2022) Congress (June 9-17; virtual and in Vienna). “We are committed to advancing science that can lead to solutions for patients with serious unmet medical needs, including those with … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Anesthetics Global Market Report 2022, Type, Application, Route of Administration, Local Anesthetics, General Anesthetics” report has been added to ResearchAndMarkets.com’s offering. The global anesthetics market is expected to grow from $9.24 billion in 2021 to $9.88 billion in 2022 at a compound annual growth rate (CAGR) of 7.0 %. The market is expected … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Anesthesia And Respiratory Devices Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global anesthesia and respiratory devices market is expected to grow from $45.25 billion in 2021 to $51.51 billion in 2022 at a compound annual growth rate (CAGR) of 13.8%. The market is expected to grow to $82.25 … [Read more…]

Addition of Aalto Bio Reagents expands Biosynth Carbosynth’s offer to its clinical diagnostics customers. STAAD, Switzerland–(BUSINESS WIRE)–Biosynth Carbosynth (“Biosynth”), a supplier of critical materials to the life science industry, announces today the acquisition of Aalto Bio Reagents (“Aalto”), a leading developer and provider of biological materials to the in-vitro diagnostic (IVD) and vaccine development industry … [Read more…]

CARVYKTI® is Legend Biotech’s first European Commission-approved product The approval is based on the pivotal phase 1b/2 CARTITUDE-1 study, which demonstrated an overall response rate (ORR) of 98 percent in patients with relapsed or refractory multiple myeloma following a one-time treatment with ciltacabtagene autoleucel SOMERSET, N.J.–(BUSINESS WIRE)–$LEGN–Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global … [Read more…]

SEATTLE–(BUSINESS WIRE)–#EHR—Health and Social Care Northern Ireland (HSCNI) has enlisted the support of global healthcare technology specialist, Tegria, and digital health consultancy, Cloud21, in a deal to support its national digital transformation programme. The organisations will help to deliver Northern Ireland’s Encompass programme – a decade long initiative that aims to deliver improvements to outcomes … [Read more…]

In the pivotal clinical study CARTITUDE-1, 98 percent of patients with relapsed or refractory multiple myeloma responded to a one-time treatment with ciltacabtagene autoleucel and 80 percent of patients who responded experienced a stringent complete response1 BEERSE, Belgium–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission (EC) granted conditional … [Read more…]

DAVIS, Calif.–(BUSINESS WIRE)–Please replace the caption with the accompanying correct caption. The release reads: BSI WINS BEST BIOTECH STARTUP BUSINESS OF THE YEAR 2022 AWARD Botanical Solution Inc. (BSI), innovator of sustainable, consistent and cost-effective Advanced Botanical Materials (ABM) for agricultural and pharmaceutical applications, has won the “Best Biotech Startup Business of the Year 2022” … [Read more…]

Partnership agreement signed with Midnight Health to deliver a world-first personalised consumer health service called Vidality Midnight Health will promote, market and sell a new subscription consumer health service driven by Microba’s core technology nib-backed (ASX: NHF) Midnight Health is a fast growth, Australian-based, digital healthcare company BRISBANE, Australia–(BUSINESS WIRE)–$MAP—Microba Life Sciences Limited (ASX: MAP) … [Read more…]